Rankings
▼
Calendar
MCK Q2 2022 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena
MCK
McKesson Corporation
$115B
Q2 2022 Earnings
Healthcare
Medical - Distribution
Income Statement
Revenue
$66.6B
+9.5% YoY
Gross Profit
$3.2B
4.8% margin
Operating Income
$683M
1.0% margin
Net Income
$267M
0.4% margin
EPS (Diluted)
$1.71
QoQ Revenue Growth
+6.2%
Cash Flow
Operating Cash Flow
$1.8B
Free Cash Flow
$1.7B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$63.6B
Total Liabilities
$63.7B
Stockholders' Equity
-$571M
Cash & Equivalents
$2.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$66.6B
$60.8B
+9.5%
Gross Profit
$3.2B
$2.9B
+12.9%
Operating Income
$683M
$804M
-15.0%
Net Income
$267M
$577M
-53.7%
Revenue Segments
U.S. Pharmaceutical Segment
$53.4B
80%
International Segment
$9.1B
14%
Medical-Surgical Solutions Segment
$3.1B
5%
Prescription Technology Solutions
$932M
1%
← FY 2022
All Quarters
Q3 2022 →